Bloomberg Law
July 10, 2019, 7:54 PM

Biomedical Innovation May Get Fresh Boost From House Duo

Jeannie Baumann
Jeannie Baumann

New biomedical innovation legislation is in the works from the bipartisan pair behind the 21st Century Cures Act, the massive 2016 law aiming at spurring new drugs and devices.

Reps. Fred Upton (R-Mich.) and Diana DeGette (D-Colo.) said in a joint statement issued July 10, exactly four years after the House passed the Cures legislation (Pub. L. 114-255), that they are “beginning to work on new bipartisan legislation that will continue to build upon the progress we have made and help us take the next step toward finding even more life-saving cures.”

Their statement was short on ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.